Larvol Delta - ASLAN-Pharmaceuticals-Announces-Acceptance-of-LateBreaking-Abstract-on-Eblasakimab-ProofofConcept-Study-in-Atopic-Dermatitis-for-Oral-Presentation-at-the-2022-American-Academy-of-Dermatology-Annual-Meeting

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/03/18/2405926/0/en/ASLAN-Pharmaceuticals-Announces-Acceptance-of-Late-Breaking-Abstract-on-Eblasakimab-Proof-of-Concept-Study-in-Atopic-Dermatitis-for-Oral-Presentation-at-the-2022-American-Academy-o.html

Mar 18, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next